Vascular Resistance
Disorders of the Autonomic Nervous System
Coronary Artery Disease I: Introduction
Cardiovascular Drugs: Classification based on Therapeutic Indications
Psychoneuroimmunology: Cardiovascular Disease
Antihypertensive Drugs: Vasodilators
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 1, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Concetta Irace1, Jaume Padilla, Claudio Carallo
1Department of Clinical and Experimental Medicine, University Magna Graecia, Catanzaro, Italy.
Assessing cardiovascular risk involves evaluating flow-mediated dilation (FMD) kinetics. Delayed vasodilation, even with significant FMD, indicates higher risk, suggesting both FMD magnitude and timing are crucial for risk assessment.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: